HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$2.95
Day range
$2.82 - $2.94
Year range
$2.22 - $5.74
Market cap
80.19M USD
Avg Volume
324.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 183.00K | -34.17% |
Operating expense | 14.41M | 104.17% |
Net income | -12.96M | -96.74% |
Net profit margin | -7.08K | -198.87% |
Earnings per share | -0.42 | 36.36% |
EBITDA | -14.19M | -110.25% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 97.58M | 159.46% |
Total assets | 102.50M | 142.91% |
Total liabilities | 9.52M | 45.36% |
Total equity | 92.97M | — |
Shares outstanding | 27.84M | — |
Price to book | 0.86 | — |
Return on assets | -32.93% | — |
Return on capital | -35.29% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -12.96M | -96.74% |
Cash from operations | -10.89M | -75.86% |
Cash from investing | -7.79M | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -18.67M | -166.72% |
Free cash flow | -6.25M | -83.99% |
About
Founded
1998
Headquarters
Website
Employees
45